Viewing Study NCT03230292


Ignite Creation Date: 2025-12-24 @ 3:37 PM
Ignite Modification Date: 2026-05-03 @ 11:21 PM
Study NCT ID: NCT03230292
Status: COMPLETED
Last Update Posted: 2022-07-22
First Post: 2017-07-24
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study to Evaluate the Long-term Safety, Tolerability and Efficacy of Bimekizumab in Adult Patients With Chronic Plaque Psoriasis
Sponsor: UCB Biopharma SRL
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Chronic Plaque Psoriasis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Psoriasis View
None Chronic Plaque Psoriasis View
None Bimekizumab View